Tutorial
Robinhood Chain
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Tutorial
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Tutorial
Data sources
SEC FORM 4
2h ago
HOUSE PTR
2h ago
SEC 13F
2h ago
ROBINHOOD CHAIN
2h ago
Public company
Tevogen Inc.
TVGN
CIK 0001860871
EDGAR filings
Open in network
○
Watch TVGN
Price
$5.56
1 year
-80.0%
Disclosed transactions
1
Buys / sells
0 / 0
Max Insider Score
21
Connections with evidence
3
Customize layout
TVGN · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
21
SH
Saadi Ryan H.
Director, Chief Executive Officer, 10% Owner
TVGN
Tevogen Inc.
Grant or award
A
—
50.00M sh
Nov 2, 2026
Nov 4, 2026
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Insider of
evidence
Saadi Ryan H.
Director, Chief Executive Officer, 10% Owner · Nov 4, 2026
← Holds over 5% of
evidence
Saadi Ryan H.
91.1% of class · Schedule 13D · Nov 3, 2026
traded Nov 2, 2026
+2d
SEC FORM 4
Evidence
Evidence
Close
Planned sales and 5% stakes
Form 144, 13D and 13G
SH
Saadi Ryan H.
May seek to influence the company · crossed on Nov 2, 2026 · 61.71M shares
91.1% of class
13D amendment · filed Nov 4, 2026
Disclosed trades
TradingView